Williams Timothy
SVP & General Counsel
Williams Timothy has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 4, 2026.
On the most recent filing, Williams Timothy is listed as SVP & General Counsel at Vanda Pharmaceuticals Inc. Inside the rolling window, Williams Timothy reported no open-market purchases and 1 open-market sale totaling $351K in VNDA.
Companies traded
Other insiders at VNDA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$351K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Williams Timothy made?
Williams Timothy has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Williams Timothy trade?
Williams Timothy has filed SEC Form 4 disclosures for 1 company, including VNDA.
When was Williams Timothy's most recent SEC Form 4 filing?
Williams Timothy's most recent SEC Form 4 filing on Tracefour is dated Mar 4, 2026.
What is Williams Timothy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Williams Timothy is listed as SVP & General Counsel.
What is Williams Timothy's total buy and sell value in the current window?
Inside the rolling retention window, Williams Timothy bought $0 and sold $351K based on SEC Form 4 filings.
What was Williams Timothy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 42,434 VNDA shares on 2026-03-02, worth $351K, per SEC Form 4 filings.